We could not find any results for:
Make sure your spelling is correct or try broadening your search.
BALTIMORE, MD -- (Marketwire) -- 08/22/08 -- Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the Southern...
Coughlin Stoia Geller Rudman & Robbins LLP (?Coughlin Stoia?) (http://www.csgrr.com/cases/inyx/) today announced that a class action has been commenced in the United States...
NEW YORK, July 12 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC:IYXI), reported that the company's Chairman & CEO, Jack Kachkar, M.D., yesterday was approved as the debtor-in-possession lender for...
NEW YORK, April 16 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC:IYXI) (BULLETIN BOARD: IYXI) , a specialty pharmaceutical company focused on niche drug-delivery technologies and products, reported...
NEW YORK, March 26 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC Bulletin Board: IYXI), a specialty pharmaceutical company focused on niche drug- delivery technologies and products, reported today...
NEW YORK, March 19 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC Bulletin Board: IYXI), a specialty pharmaceutical company focused on niche drug- delivery technologies and products, reported today...
NEW YORK, Jan. 31 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC:IYXI) (BULLETIN BOARD: IYXI) , a specialty pharmaceutical company focused on niche drug-delivery technologies and products, announced...
NEW YORK, Jan. 25 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC:IYXI) (BULLETIN BOARD: IYXI) , a specialty pharmaceutical company focused on niche drug-delivery technologies and products, reported...
NEW YORK, Dec. 21 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC:IYXI) (BULLETIN BOARD: IYXI) , a specialty pharmaceutical company focused on niche drug-delivery technologies and products, announced...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | -9.9E-5 | -99 | 0.0001 | 0.0001 | 1.0E-6 | 50 | 1.0E-6 | CS |
26 | -9.9E-5 | -99 | 0.0001 | 0.0001 | 1.0E-6 | 20 | 1.0E-6 | CS |
52 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 3500 | 1.279E-5 | CS |
156 | -0.000199 | -99.5 | 0.0002 | 0.0002 | 1.0E-6 | 42930 | 9.648E-5 | CS |
260 | -0.001599 | -99.9375 | 0.0016 | 0.0124 | 1.0E-6 | 128501 | 0.00390587 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions